<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02273024</url>
  </required_header>
  <id_info>
    <org_study_id>14-7699</org_study_id>
    <nct_id>NCT02273024</nct_id>
  </id_info>
  <brief_title>Exercise Prior to Allogeneic Hematologic Stem Cell Transplantation</brief_title>
  <official_title>Exercise Therapy for Patients Awaiting Allogeneic Hematological Stem Cell Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Princess Margaret Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Toronto Rehabilitation Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that inactivity during the search for a donor may exacerbate
      current deconditioned states; subsequently, influencing risk factors for post-transplant
      complications that hinder the recovery phase.

      This study is designed to investigate if exercise therapy administered prior to allogeneic
      hematologic stem cell transplantation (HSCT) can influence physical and psychological
      side-effects associated with HSCT. Approximately 6-weeks prior to HSCT, individuals will be
      randomized into either an exercise group or usual care group and followed until one year
      after HSCT.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Physical Function</measure>
    <time_frame>Baseline, 1 week pre HSCT, T100, 1yr post HSCT</time_frame>
    <description>Cardiopulmonary Capacity (VO2peak)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life</measure>
    <time_frame>Baseline, 1 week pre HSCT, T100, 1yr post HSCT</time_frame>
    <description>European Organization for Research and Treatment of Cancer (EORTC) core 30-item questionnaire (QLQ-30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Symptoms</measure>
    <time_frame>Baseline, 1 week pre HSCT, T100, 1yr post HSCT</time_frame>
    <description>Memorial Symptom Assessment Scale (MSAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Anxiety</measure>
    <time_frame>Baseline, 1 week pre HSCT, T100, 1yr post HSCT</time_frame>
    <description>The Generalized Anxiety Disorder (GAD7)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Depression</measure>
    <time_frame>Baseline, 1 week pre HSCT, T100, 1yr post HSCT</time_frame>
    <description>The Patient Health Questionnaire (PHQ-9), will be used as a clinically relevant measure to evaluate depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Fatigue</measure>
    <time_frame>Baseline, 1 week pre HSCT, T100, 1yr post HSCT</time_frame>
    <description>Multidimensional Fatigue Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Treatment Side-effects</measure>
    <time_frame>Baseline, 1 week pre HSCT, T100, 1yr post HSCT</time_frame>
    <description>Hospitalization (days till discharge and readmission rates), bone marrow engraftment (days), graft versus host disease incidence (acute &amp; chronic), severity of diarrhea/ vomiting/ nausea, infections, steroid use, blood counts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Strength</measure>
    <time_frame>Baseline, 1 week pre HSCT, T100, 1yr post HSCT</time_frame>
    <description>upper body: grip strength; lower body: chair-stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Six-minute walk test</measure>
    <time_frame>Baseline, 1 week pre HSCT, T100, 1yr post HSCT</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Adherence to exercise sessions</measure>
    <time_frame>One year</time_frame>
    <description>Feasibility of an exercise intervention prior to HSCT till T100</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Allogeneic Stem Cell Transplantation</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals will participate in weekly supervised and unsupervised exercise sessions prior to HSCT, during hospitalization and till 100 days from HSCT. Exercise will consist of endurance and resistance exercise 3-5 days a week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care will have continue with standard of care treatment without any specific exercise instruction or guidance other than what is provided by the patient education team at the cancer centre.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Medical indication: allogeneic stem cell transplantation at Princess Margaret Hospital

          -  must be ambulatory without need for human assistance at time of recruitment

          -  medically cleared to exercise by the transplant physician

          -  demonstrates willingness to attend supervised sessions

          -  sufficient in English to ensure safety of understanding prescribed exercise
             guidelines, or has access to an adequate non-familial interpreter

        Exclusion Criteria:

          -  another active malignancy

          -  less than 4 weeks till the scheduled HSCT

          -  refusal to be randomized

          -  does not have the approval of their transplant physician

          -  severe or unstable neurological, cardiorespiratory, musculoskeletal disease or mental
             illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeff Lipton, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Princess Margaret Hospital, University Health Network</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lianne Dolan, PhD</last_name>
    <phone>416-597-3422</phone>
    <phone_ext>4521</phone_ext>
    <email>lianne.dolan@uhnresearch.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eugene Chang, MD</last_name>
    <phone>416-597-3422</phone>
    <phone_ext>4521</phone_ext>
    <email>eugene.chang@uhn.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Princess Margaret Hospital &amp; Toronto Rehabilitation Institute</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lianne Dolan, PhD</last_name>
      <phone>416-597-3422</phone>
      <phone_ext>5223</phone_ext>
      <email>lianne.dolan@uhnresearch.ca</email>
    </contact>
    <contact_backup>
      <last_name>Eugene Chang, MD</last_name>
      <phone>416-597-3422</phone>
      <phone_ext>4521</phone_ext>
      <email>eugene.chang@uhn.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Jeff Lipton, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2014</study_first_submitted>
  <study_first_submitted_qc>October 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2014</study_first_posted>
  <last_update_submitted>March 4, 2016</last_update_submitted>
  <last_update_submitted_qc>March 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exercise</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Fatigue</keyword>
  <keyword>Symptoms</keyword>
  <keyword>Prehabilitation</keyword>
  <keyword>Aerobic Capacity</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

